Equities

Anpario PLC

ANP:LSE

Anpario PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)255.00
  • Today's Change0.00 / 0.00%
  • Shares traded10.63k
  • 1 Year change-2.86%
  • Beta1.0174
Data delayed at least 20 minutes, as of Apr 26 2024 16:29 BST.
More ▼

Profile data is unavailable for this security.

About the company

Anpario plc is a United Kingdom-based independent manufacturer of natural sustainable feed additives for animal health, nutrition and biosecurity. The Company's main focus is understanding animals' intestinal health and nutrition. Its feed addictive solutions include poultry, ruminant, swine, aqua and feed mill. Its product categories include health & performance, toxin management, feed quality, and hygiene & insect control. Its health & performance products include Orego-Stim Range, Orego-Stim Range (Aqua), pHorce Range, Salkil Range, Optomega Range and Genex Range. Its toxin management products include Anpro Range and Anpro Advance. Its feed quality products include pHorce Range, Salgard Range, Mastercube Range, Moldgard, Oxigard Range and Feedzyme Range. Its hygiene & insect control products include Mitex, Clean & Dry and Credence. Its technologies are sold in over 80 countries through established sales and distribution networks, which includes a number of wholly owned subsidiaries.

  • Revenue in GBP (TTM)31.00m
  • Net income in GBP2.53m
  • Incorporated1997
  • Employees100.00
  • Location
    Anpario PLCManton Wood Enterprise Park,WORKSOP S80 2RSUnited KingdomGBR
  • Phone+44 19 0953 7380Fax+44 19 0947 8919
  • Websitehttps://www.anpario.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Loulis Food Ingredients SA171.62m4.36m40.31m380.0040.31m380.00
Makarony Polskie SA70.35m6.52m45.97m396.0045.97m396.00
Schwaelbchen Molkerei Jakob Berz AG-85.61bn-85.61bn47.94m385.0047.94m385.00
Enervit SpA73.11m3.60m48.31m233.0048.31m233.00
Skane mollan AB19.37m1.05m49.98m29.0049.98m29.00
Altinyag Madencilik v Enr Ytr Sny v T AS4.73m4.63m51.72m45.0051.72m45.00
Anpario PLC31.00m2.53m51.80m100.0051.80m100.00
Pinar Su ve Icecek Sanayi ve Ticaret AS21.33m-494.28k54.15m398.0054.15m398.00
Saint Jean Groupe99.00m3.58m54.89m493.0054.89m493.00
Vilkyskiu pienine AB180.25m12.56m55.62m919.0055.62m919.00
Pieno Zvaigzdes AB172.18m11.35m56.03m1.56k56.03m1.56k
HKScan Oyj995.87m-18.15m56.07m3.62k56.07m3.62k
WASGAU Produktions & Handels AG532.85m4.46m56.51m3.76k56.51m3.76k
Hofseth Biocare ASA15.84m-7.74m59.87m62.0059.87m62.00
Miko NV248.11m1.88m61.46m1.31k61.46m1.31k
Zemaitijos Pienas AB238.01m18.20m62.18m1.40k62.18m1.40k
Data as of Apr 26 2024. Currency figures normalised to Anpario PLC's reporting currency: UK Pound GBX

Institutional shareholders

40.75%Per cent of shares held by top holders
HolderShares% Held
Unicorn Asset Management Ltd.as of 29 Feb 20241.87m9.18%
Interactive Investor Services Ltd.as of 29 Feb 20241.55m7.64%
Hargreaves Lansdown Asset Management Ltd.as of 29 Feb 20241.30m6.39%
BGF Investment Management Ltd.as of 29 Feb 2024811.00k3.99%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 30 Dec 2022620.22k3.05%
Foresight Group LLP (Investment Management)as of 29 Feb 2024616.00k3.03%
Sorbus Partners LLPas of 28 Mar 2024578.30k2.85%
Castlefield Investment Partners LLPas of 29 Sep 2023345.00k1.70%
Fiske Plc (Broker)as of 01 Sep 2023304.00k1.50%
BlackRock Investment Management (UK) Ltd.as of 31 Mar 2023287.37k1.42%
More ▼
Data from 29 Sep 2023 - 12 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.